Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer

Genes Chromosomes and Cancer

Volumn 26, Issue 4, 1999, Pages 286-294

  Izatt, Louise ^a,b   Greenman, Jill ^a   Hodgson, Shirley ^a   Ellis, David ^a   Watts, Sally ^a   Scott, Gillian ^a   Jacobs, Chris ^a   Liebmann, Rachael ^b   Zvelebil, Marketa J ^c   Mathew, Christopher ^a   Solomon, Ellen ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; AGED; ALLELES; AMINO ACID SEQUENCE; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; RNA, NEOPLASM; SEQUENCE ALIGNMENT;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0032756367     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X     Document Type: Article

References (37)

1. Anonymous. 1995. LENT SOMA tables. Radiother Oncol 35:17-60.
2. Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, Warren C, Scott D. 1997. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76:1546-1549.
3. Athma P, Rappaport R, Swift M. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygores are predisposed to breast cancer. Cancer Gen Cytogen 92:130-134.
4. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. 1993. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67:1262-1267.
5. Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A. 1998. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 58:1376-1379.
6. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
7. Easton DF. 1994. Cancer risks in A-T heterozygotes, Int J Radiat Biol 66:S177-8182.
8. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307-310.
9. Gabra H, Taylor L, Cohen BB, Lessels A, Eccles DM, Leonard RC, Smyth JF, Steel CM. 1995. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer 72:367-375.
10. Gatti RA, McConville CM, Taylor AM. 1994. Sixth international workshop on ataxia-telangiectasia. Cancer Res 54:6007-6010.
11. Greenman J, Mohammed S, Ellis D, Watts S, Scott G, Izatt L, Barnes D, Solomon E, Hodgson S, Mathew C. 1998. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosomes Cancer 21:244-249.
12. Gustafson CE, Young J, Leggett B, Searle J, Chenevix-Trench G. 1994. Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. Br J Cancer 70:395-397.
13. Haliassos A, Chomel JC, Tesson L, Baudis M, Kruh J, Kaplan JC, Kitzis A. 1989. Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17:3606.
14. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RM, Williams AW, Steel CM, Bird CC, Stambridge EJ, Evans GA. 1994. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
15. Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC. 1995. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res 55:2494-2496.
16. Izatt L, Vessey C, Hodgson SV, Solomon E. 1999. Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations. Eur J Hum Genet 7:310-320.
17. Jones LA, Scott D, Cowan R, Roberts SA. 1995. Abnormal diosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol 67:519-528.
18. Laake K, Odegard A, Andersen TI, Bukholm IK, Karesen R, Nesland JM, Ottestad L, Shiloh Y, Borresen-Dale AL. 1997. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18:175-180.
19. Lavin MF, Shiloh Y. 1997. The genetic defect in ataxia-telangiectasia. Ann Rev Immunol 15:177-202.
20. Man S, Ellis IO, Sibbering M, Blamey RW, Brook JD. 1996. High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 56:5484-5489.
21. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
22. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce CM. 1995. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55:3003-3007.
23. Pecker I, Avraham KB, Gilbert DJ, Savitsky K, Rotman G, Harnik R, Fukao T, Schrock E, Hirotsune S, Tagle DA, Collins FS, Wynshaw-Boris A, Ried T, Copeland NG, Jenkins NA, Shiloh Y, Ziv Y. 1996. Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia gene. Genomics 35:39-45.
24. Pippard EC, Hall AJ, Barker DJ, Bridges BA. 1988. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2932.
25. Platzer M, Rotman G. Bauer D, Uziel T, Savitsky K, Bar-Shira A, Gilad S, Shiloh Y, Rosenthal A. 1997. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7:592-605.
26. Ramsay J, Birrell G, Baumann K, Bodero A, Parsons P, Lavin M. 1998a. Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia. Br J Cancer 77:11-14.
27. Ramsay J, Birrell G, Lavin M. 1998b. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47:125-128.
28. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman TS, Lovett M, Collins FS, Shiloh Y. 1995a. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
29. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. 1995b. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032.
30. Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A, Moohan M, Wooster R, Owen R, Bliss JM, Stratton MR, Yarnold J. 1998. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78:922-927.
31. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AMR. 1998. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345.
32. Swift M, Morrell D, Massey RB, Chase CL. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836.
33. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
34. Vorechovsky I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM, Hammarstrom L. 1996a. ATM mutations in cancer families. Cancer Res 56:4130-4133.
35. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster AD, Zaloudik J, Barbanti-Brodani G, James M, Russo G, Croce CM, Negrini M. 1996b. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732.
36. Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster AD, Yuille MA. 1997. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17:96-99.
37. West CM, Elyan SA, Berry P, Cowan R, Scott D. 1995. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int J Radiat Biol 68:197-203.